François Bertelli

CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity

Francesca Zammarchi, Karin Havenith, François Bertelli et al. · Journal for ImmunoTherapy of Cancer · 2020 · 77 citations · Full text

Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer

Song Cho, Francesca Zammarchi, David G. Williams et al. · Molecular Cancer Therapeutics · 2018 · 46 citations

Development and Automation of a 384-Well Cell Fusion Assay to Identify Inhibitors of CCR5/CD4-Mediated HIV Virus Entry

Joe Bradley, Jasween Gill, François Bertelli et al. · SLAS DISCOVERY · 2004 · 38 citations · Full text

Trypanosoma brucei Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public-Private Partnership to Identify Novel Leads

Richard Oduor, Kayode K. Ojo, Gareth Williams et al. · PLoS neglected tropical diseases · 2011 · 33 citations · Full text

The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTS

McLoughlin Dj, François Bertelli, Christine A. Williams · Expert Opinion on Drug Discovery · 2007 · 21 citations

Drug Target, Hit Identification, Lead Identification +19